Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page
- CheckyesterdayChange DetectedThe page changed from an error page to a full study record for NCT03498612, adding the study overview, design details, eligibility criteria, locations, outcomes, and links to related documents such as the Study Protocol and Statistical Analysis Plan.SummaryDifference52%

- Check8 days agoChange DetectedRevision: v3.6.5 replaces v3.6.4 on the page. This appears to be a small site maintenance update rather than a change to the study information.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows a revised tag, updating from v3.6.3 to v3.6.4, indicating a minor site update. This does not alter study details or how the page operates.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, representing a small update to the page metadata.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, indicating an internal update to the page. This does not modify the displayed study information, eligibility criteria, or results.*SummaryDifference0.1%

- Check65 days agoChange DetectedThe study page now includes a recruitment status note indicating recruitment is closed ('No longer looking for participants'), and adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) with an updated Intervention/Treatment label. The previous label 'Intervention / Treatment' and the older 'Revision: v3.5.5' are removed and replaced with 'Revision: v3.6.0'.SummaryDifference0.6%

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.